Saving Lives: The Benefits of Subcutaneous Injection Chambers for Cancer Patients at Risk of Extravasation

Cancer patients at risk of extravasation during chemotherapy can benefit from the subcutaneous injection chamber technique, which reduces the risk of skin necrosis and limits drug side effects. The technique involves implanting a device under the skin of the chest wall to support intravenous drug and nutrition infusion, providing a more secure and convenient method of drug delivery. Dr. Luu Kinh Khuong, Head of the Department of Anesthesiology and Resuscitation at Tam Anh General Hospital in Ho Chi Minh City, explained that chemotherapy drugs are typically administered through external intravenous lines, which can lead to damage to peripheral blood vessels, inflammation, and the risk of extravasation due to vein deviation, resulting in limited movement for the patient.

Extravasation is a common complication when injecting drugs into peripheral veins, causing irritation, ulcers, and skin necrosis. Older patients, those with weak vessel walls, obesity, edema or skin lesions are more susceptible to this condition. To address this issue, a subcutaneous injection chamber is often used for patients at risk of extravasation due to chemotherapy at Tam Anh General Hospital. This device allows for targeted delivery of chemotherapy drugs without the risk of complications associated with intravenous administration, resulting in reduced side effects and improved outcomes. Patients can continue their treatment with confidence and without the limitations imposed by traditional IV drug delivery methods.

The procedure for implanting a subcutaneous injection chamber involves placing the device under the skin of the chest wall with a catheter inserted into a central vein to facilitate drug delivery. The incision is sutured and bandaged to prevent infection, and patients can resume their daily activities once the device is in place. Regular monitoring and care are required to ensure the longevity and effectiveness of the subcutaneous injection chamber which can last up to 1-2 years before replacement may be necessary.

Overall, incorporating innovative technologies like subcutaneous injection chambers into cancer care improves patient outcomes by reducing side effects associated with traditional IV drug delivery methods while providing a more comfortable treatment experience for patients at risk of extravasation during chemotherapy treatment options available at Tam Anh General Hospital.